AMGN
Amgen Inc. (AMGN) Amgen Announces Positive Topline Phase 3 Results For Subcutaneous Tepezza In Adults Living With Moderate-To-Severe Active Thyroid Eye Disease
Amgen Inc. (NASDAQ: AMGN) FY 2026 Other Release
Amgen Inc. (AMGN) 2026 J.P. Morgan Healthcare Conference
Amgen Inc. (NASDAQ: AMGN) FY 2026 Corporate Conference
Amgen Inc. (AMGN) Repatha® Cuts Risk Of First Major Cardiovascular Events By 31% In High-risk Patients Without Known Significant Atherosclerosis
Amgen Inc. (NASDAQ: AMGN) FY 2026 Other Release
Amgen Inc. (AMGN) Leerink Partners 2026 Global Healthcare Conference
Amgen Inc. (NASDAQ: AMGN) FY 2026 Corporate Conference
Amgen Inc. (AMGN) Dividend Update
Amgen Inc. (NASDAQ: AMGN) Q2 2026 Dividend Update
Amgen Inc. (AMGN) 46th Annual TD Cowen Health Care Conference
Amgen Inc. (NASDAQ: AMGN) FY 2026 Corporate Conference
Amgen Inc. (AMGN) Sec Form 8K
Amgen Inc. (NASDAQ: AMGN) Sec Form 8K
Amgen Inc. (AMGN) Sec Form 10K
Amgen Inc. (NASDAQ: AMGN) Sec Form 10K
Amgen Inc. (AMGN) Summit Meeting
Amgen Inc. (NASDAQ: AMGN) Summit Meeting
Amgen Inc. (AMGN) Q4 2025 Earnings Call Transcript
Amgen Inc. (NASDAQ: AMGN) Q4 2025 Earnings Call dated Feb. 03, 2026 Corporate Participants: Casey Capparelli — Vice President, Investor…